Clinical trial
An Open Label Phase I Clinical Trial to Evaluate the Effect of Late Boost on HIV-uninfected Vaccinees From EV06 Trial
NCT03391375 is registered in ClinicalTrials.gov with EuroVacc Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Phase I Clinical Trial to Evaluate the Effect of Late Boost on HIV-uninfected Vaccinees From EV06 Trial
- Lead sponsor
- EuroVacc Foundation
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 15, 2017
- Completion date
- July 31, 2018
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv/aids